Anxiety (partial update)
Summary - final scope
[Anticipated publication date January 2011]The full text of the final scope is available for download here.
- Pharmacological interventions compared with: placebo, other pharmacological interventions (those available in the UK according to the British National Formulary), psychological interventions, or combined psychological and pharmacological treatment for
Anxiety (partial update) scope July 2009 Page 4 of 13
generalised anxiety disorder. This will include selective serotonin reuptake inhibitors [SSRIs] (and related drugs), duloxetine, venlafaxine, tricyclic antidepressants, benzodiazepines, azapirones, antihistamines, beta-blockers, antipsychotics. - When referring to pharmacological interventions, the guideline will normally recommend use within licensed indications. Exceptionally, and only where the evidence supports it, the guideline may recommend use outside a treatment's licensed indications. The guideline will expect that prescribers will use the Summary of Product Characteristics to inform their prescribing decisions for individual patients.
- Psychological interventions compared with: control groups (such as treatment as usual), other psychological interventions, pharmacological interventions, or combined psychological and pharmacological treatment for generalised anxiety disorder. This will include cognitive behavioural therapy (CBT), guided self help, counselling, and short term psychodynamic psychotherapy.
- The Guideline Development Group will also review the structure of recommendations of the original guideline and care pathways on which it is based to ensure fit with other NICE guidelines for common mental health disorders.
- The delivery of computerised cognitive behaviour therapy (CCBT) for panic disorder and generalised anxiety disorder.
- Diagnosis
- Pharmacological and psychological interventions for panic disorder (with or without agoraphobia)
Areas that will be covered by the guideline:
Areas that will not be covered by the guideline:
Documents
[Guideline documents for download]- CG72 Attention deficit hyperactivity disorder (ADHD): full guideline
- CG72 Attention deficit hyperactivity disorder (ADHD): full guideline appendices
- CG72 Attention deficit hyperactivity disorder (ADHD): NICE guideline
- CG72 Attention deficit hyperactivity disorder (ADHD): NICE guideline (MS Word format)
- CG72 Attention deficit hyperactivity disorder (ADHD): NICE quick reference guide
- CG72 Attention deficit hyperactivity disorder (ADHD): understanding NICE guidance
- CG72 Attention deficit hyperactivity disorder (ADHD): understanding NICE guidance (MS Word format)
For healthcare professionals [NCCMH and NICE documents]
For patients, carers and the public [NICE documents]
Background information [NICE documents]
Implementation
[Information to help you implement this guideline locally]- Attention deficit hyperactivity disorder (ADHD): NICE costing report
- Attention deficit hyperactivity disorder (ADHD): NICE costing template
- Attention deficit hyperactivity disorder (ADHD): NICE slide set
- Attention deficit hyperactivity disorder (ADHD): NICE implementation advice
- Attention deficit hyperactivity disorder (ADHD): NICE audit support (children and young people)
- Attention deficit hyperactivity disorder (ADHD): NICE audit support (adults)
